Related Experiment Videos
[Successful drug therapy in Aspergillus endocarditis]
J R Bogner1, S Lüftl, M Middeke
1Medizinische Poliklinik, Universität München.
Deutsche Medizinische Wochenschrift (1946)
|November 30, 1990
Summary
This case study highlights a rare instance of Aspergillus endocarditis in an elderly male. Successful treatment with amphotericin B and flucytosine was achieved without valve replacement.
Area of Science:
- Cardiology
- Infectious Diseases
- Mycology
Background:
- Infective endocarditis is a serious condition, often caused by bacteria, but fungal causes like Aspergillus are rare.
- Elderly patients with comorbidities present unique challenges for treatment and management.
Observation:
- A 74-year-old man presented with weight loss, fever, anemia, and peripheral ischemic symptoms (blue discoloration of fingers).
- Echocardiography revealed aortic valve vegetations, and blood cultures confirmed Aspergillus fumigatus, diagnosing Aspergillus endocarditis.
- The patient had no identifiable predisposing factors for fungal endocarditis.
Findings:
- Due to patient age and comorbidities (peripheral arterial disease, myocardial infarction), valve replacement was contraindicated.
- Intravenous amphotericin B and oral flucytosine were administered for five weeks, achieving a total dose of 1.1g amphotericin B and 41.5g flucytosine.
- The patient showed a gradual decrease in symptoms and resolution of valve vegetations during treatment.
Implications:
- This case demonstrates the successful medical management of Aspergillus endocarditis in a high-risk elderly patient.
- Aggressive antifungal therapy can be effective even when surgical intervention is not feasible.
- Early diagnosis and prompt treatment are crucial for favorable outcomes in rare fungal endocarditis cases.